438 related articles for article (PubMed ID: 31570878)
1. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
[TBL] [Abstract][Full Text] [Related]
2. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins.
Dang HV; Cross RW; Borisevich V; Bornholdt ZA; West BR; Chan YP; Mire CE; Da Silva SC; Dimitrov AS; Yan L; Amaya M; Navaratnarajah CK; Zeitlin L; Geisbert TW; Broder CC; Veesler D
Nat Struct Mol Biol; 2021 May; 28(5):426-434. PubMed ID: 33927387
[TBL] [Abstract][Full Text] [Related]
3. Prefusion stabilization of the Hendra and Langya virus F proteins.
Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
[TBL] [Abstract][Full Text] [Related]
4. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
[TBL] [Abstract][Full Text] [Related]
5. Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head Domain.
Yeo YY; Buchholz DW; Gamble A; Jager M; Aguilar HC
J Virol; 2021 Sep; 95(20):e0066621. PubMed ID: 34288734
[TBL] [Abstract][Full Text] [Related]
6. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
[TBL] [Abstract][Full Text] [Related]
7. Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes.
Oguntuyo KY; Haas GD; Azarm KD; Stevens CS; Brambilla L; Kowdle SS; Avanzato VA; Pryce R; Freiberg AN; Bowden TA; Lee B
J Virol; 2024 Mar; 98(3):e0183823. PubMed ID: 38426726
[TBL] [Abstract][Full Text] [Related]
8. Detailed Molecular Biochemistry for Novel Therapeutic Design Against Nipah and Hendra Virus: A Systematic Review.
Bhattacharya S; Dhar S; Banerjee A; Ray S
Curr Mol Pharmacol; 2020; 13(2):108-125. PubMed ID: 31657692
[TBL] [Abstract][Full Text] [Related]
9. Structure and design of Langya virus glycoprotein antigens.
Wang Z; McCallum M; Yan L; Gibson CA; Sharkey W; Park YJ; Dang HV; Amaya M; Person A; Broder CC; Veesler D
Proc Natl Acad Sci U S A; 2024 Apr; 121(16):e2314990121. PubMed ID: 38593070
[TBL] [Abstract][Full Text] [Related]
10. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
[TBL] [Abstract][Full Text] [Related]
11. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
12. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.
Mire CE; Chan YP; Borisevich V; Cross RW; Yan L; Agans KN; Dang HV; Veesler D; Fenton KA; Geisbert TW; Broder CC
J Infect Dis; 2020 May; 221(Suppl 4):S471-S479. PubMed ID: 31686101
[TBL] [Abstract][Full Text] [Related]
13. A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex.
Avanzato VA; Oguntuyo KY; Escalera-Zamudio M; Gutierrez B; Golden M; Kosakovsky Pond SL; Pryce R; Walter TS; Seow J; Doores KJ; Pybus OG; Munster VJ; Lee B; Bowden TA
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25057-25067. PubMed ID: 31767754
[TBL] [Abstract][Full Text] [Related]
14. Henipavirus mediated membrane fusion, virus entry and targeted therapeutics.
Steffen DL; Xu K; Nikolov DB; Broder CC
Viruses; 2012 Feb; 4(2):280-308. PubMed ID: 22470837
[TBL] [Abstract][Full Text] [Related]
15. Novel Roles of the N1 Loop and N4 Alpha-Helical Region of the Nipah Virus Fusion Glycoprotein in Modulating Early and Late Steps of the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; Aguilar HC
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568505
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
[TBL] [Abstract][Full Text] [Related]
17. Architecture and antigenicity of the Nipah virus attachment glycoprotein.
Wang Z; Amaya M; Addetia A; Dang HV; Reggiano G; Yan L; Hickey AC; DiMaio F; Broder CC; Veesler D
Science; 2022 Mar; 375(6587):1373-1378. PubMed ID: 35239409
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane Domain Dissociation Is Required for Hendra Virus F Protein Fusogenic Activity.
Slaughter KB; Dutch RE
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462574
[TBL] [Abstract][Full Text] [Related]
19. Henipavirus W Proteins Interact with 14-3-3 To Modulate Host Gene Expression.
Edwards MR; Hoad M; Tsimbalyuk S; Menicucci AR; Messaoudi I; Forwood JK; Basler CF
J Virol; 2020 Jul; 94(14):. PubMed ID: 32321809
[TBL] [Abstract][Full Text] [Related]
20. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.
Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC
J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
